Cytocompatibility and Synergy of EGCG and Cationic Peptides Against Bacteria Related to Endodontic Infections, in Planktonic and Biofilm Conditions

Overview

Journal Probiotics Antimicrob Proteins

Publisher Springer

Specialties Infectious Diseases
Microbiology
Nutritional Sciences
Pharmacology

Date 2021 Aug 17

PMID 34402021

Citations 9

Authors

Karina Sampaio Caiaffa

Vanessa Rodrigues Dos Santos

Gabriel Flores Abuna

Norival Alves Santos-Filho

Eduardo Maffud Cilli

Vivien Thiemy Sakai

Luciano Tavares Angelo Cintra

Cristiane Duque

Affiliations

Soon will be listed here.

Abstract

This study evaluated the cytocompatibility and antimicrobial/antibiofilm effects of epigallocatechin-3-gallate (EGCG) associated with peptide LL-37 and its analogue KR-12-a5 against oral pathogens. The effect of the compounds on metabolism of fibroblasts was evaluated by methyltetrazolium assays. Antimicrobial activity of the compounds was evaluated on Streptococcus mutans, Enterococcus faecalis, Actinomyces israelii, and Fusobacterium nucleatum under planktonic conditions, on single- and dual-species biofilms and E. faecalis biofilms in dentinal tubules and analyzed by bacterial counts and confocal microscopy. Data were statistically analyzed considering p < 0.05. EGCG and peptide combinations were not toxic to fibroblasts. KR-12-a5 showed synergistic or addictive effects with EGCG and LL-37 against all bacteria tested. However, EGCG associated with KR-12-a5 demonstrated the highest bactericidal activity on all bacteria tested, at lower concentrations. In single-species biofilms, EGCG + KR-12-a5 eliminated S. mutans and A. israelii and reduced E. faecalis and F. nucleatum counts around 5 log CFU/mL. EGCG + KR-12-a5 reduced E. faecalis (-3.93 log CFU/mL) and eliminated S. mutans in dual-species biofilms. No growth of E. faecalis and significant reduction in A. israelii (-6.24 log CFU/mL) and F. nucleatum (-4.62 log CFU/mL) counts were detected in dual-species biofilms. The combination of EGCG and KR-12-a5 led to 88% of E. faecalis dead cells inside dentin tubules. The association of EGCG and KR-12-a5 was cytocompatible and promoted synergistic effect against biofilms of bacteria associated with endodontic infections.

Citing Articles

Natural Antibacterial Compounds with Potential for Incorporation into Dental Adhesives: A Systematic Review.

Sousa A, Mascarenhas P, Polido M, Vasconcelos E Cruz J Polymers (Basel). 2024; 16(22).

PMID: 39599308 PMC: 11598765. DOI: 10.3390/polym16223217.

Antimicrobial Peptides: A Promising Alternative to Conventional Antimicrobials for Combating Polymicrobial Biofilms.

Roque-Borda C, Primo L, Medina-Alarcon K, Campos I, de Fatima Nascimento C, Saraiva M Adv Sci (Weinh). 2024; 12(1):e2410893.

PMID: 39530703 PMC: 11714181. DOI: 10.1002/advs.202410893.

Origami of KR-12 Designed Antimicrobial Peptides and Their Potential Applications.

Lakshmaiah Narayana J, Mechesso A, Rather I, Zarena D, Luo J, Xie J Antibiotics (Basel). 2024; 13(9).

PMID: 39334990 PMC: 11429261. DOI: 10.3390/antibiotics13090816.

Effects of Green Tea Extract Epigallocatechin-3-Gallate on Oral Diseases: A Narrative Review.

Li Y, Cheng L, Li M Pathogens. 2024; 13(8).

PMID: 39204235 PMC: 11357325. DOI: 10.3390/pathogens13080634.

Controlled Release of Drugs from Extracellular Matrix-Derived Peptide-Based Nanovesicles through Tailored Noncovalent Interactions.

Huang H, Hwang J, Anilkumar S, Kiick K Biomacromolecules. 2024; 25(4):2408-2422.

PMID: 38546162 PMC: 11661555. DOI: 10.1021/acs.biomac.3c01361.

References

Nkhili E, Tomao V, El Hajji H, El Boustani E, Chemat F, Dangles O . Microwave-assisted water extraction of green tea polyphenols. Phytochem Anal. 2009; 20(5):408-15. DOI: 10.1002/pca.1141. View

Saito S, Gosmann G, Pungartnik C, Brendel M . Green tea extract-patents and diversity of uses. Recent Pat Food Nutr Agric. 2010; 1(3):203-15. DOI: 10.2174/2212798410901030203. View

Chacko S, Thambi P, Kuttan R, Nishigaki I . Beneficial effects of green tea: a literature review. Chin Med. 2010; 5:13. PMC: 2855614. DOI: 10.1186/1749-8546-5-13. View

Legeay S, Rodier M, Fillon L, Faure S, Clere N . Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome. Nutrients. 2015; 7(7):5443-68. PMC: 4517007. DOI: 10.3390/nu7075230. View

Lee P, Tan K . Effects of Epigallocatechin gallate against Enterococcus faecalis biofilm and virulence. Arch Oral Biol. 2014; 60(3):393-9. DOI: 10.1016/j.archoralbio.2014.11.014. View

Xu X, Zhou X, Wu C . Tea catechin epigallocatechin gallate inhibits Streptococcus mutans biofilm formation by suppressing gtf genes. Arch Oral Biol. 2011; 57(6):678-83. DOI: 10.1016/j.archoralbio.2011.10.021. View

Holzl M, Hofer J, Steinberger P, Pfistershammer K, Zlabinger G . Host antimicrobial proteins as endogenous immunomodulators. Immunol Lett. 2008; 119(1-2):4-11. DOI: 10.1016/j.imlet.2008.05.003. View

Zhang Z, Cherryholmes G, Shively J . Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J Leukoc Biol. 2008; 84(3):780-8. PMC: 2516901. DOI: 10.1189/jlb.0208086. View

Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M . Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother. 2005; 55(6):888-96. DOI: 10.1093/jac/dki103. View

10.

Caiaffa K, Massunari L, Danelon M, Abuna G, Bedran T, Santos-Filho N . KR-12-a5 is a non-cytotoxic agent with potent antimicrobial effects against oral pathogens. Biofouling. 2017; 33(10):807-818. DOI: 10.1080/08927014.2017.1370087. View

11.

Wong J, Ng T, Legowska A, Rolka K, Hui M, Cho C . Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans. Peptides. 2011; 32(10):1996-2002. DOI: 10.1016/j.peptides.2011.08.018. View

12.

Suphasiriroj W, Mikami M, Shimomura H, Sato S . Specificity of antimicrobial peptide LL-37 to neutralize periodontopathogenic lipopolysaccharide activity in human oral fibroblasts. J Periodontol. 2012; 84(2):256-64. DOI: 10.1902/jop.2012.110652. View

13.

Jacob B, Park I, Bang J, Shin S . Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity. J Pept Sci. 2013; 19(11):700-7. DOI: 10.1002/psc.2552. View

14.

Harasstani O, Moin S, Tham C, Liew C, Ismail N, Rajajendram R . Flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells. Inflamm Res. 2010; 59(9):711-21. DOI: 10.1007/s00011-010-0182-8. View

15.

Feldman M, Grenier D . Cranberry proanthocyanidins act in synergy with licochalcone A to reduce Porphyromonas gingivalis growth and virulence properties, and to suppress cytokine secretion by macrophages. J Appl Microbiol. 2012; 113(2):438-47. DOI: 10.1111/j.1365-2672.2012.05329.x. View

16.

Ji S, Hyun J, Park E, Lee B, Kim K, Choi Y . Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res. 2007; 42(5):410-9. DOI: 10.1111/j.1600-0765.2006.00962.x. View

17.

Tong Z, Zhou L, Jiang W, Kuang R, Li J, Tao R . An in vitro synergetic evaluation of the use of nisin and sodium fluoride or chlorhexidine against Streptococcus mutans. Peptides. 2011; 32(10):2021-6. DOI: 10.1016/j.peptides.2011.09.002. View

18.

Massunari L, Novais R, Oliveira M, Valentim D, Dezan Junior E, Duque C . Antimicrobial Activity and Biocompatibility of the Psidium cattleianum Extracts for Endodontic Purposes. Braz Dent J. 2018; 28(3):372-379. DOI: 10.1590/0103-6440201601409. View

19.

Gao Y, Jiang X, Lin D, Chen Y, Tong Z . The Starvation Resistance and Biofilm Formation of Enterococcus faecalis in Coexistence with Candida albicans, Streptococcus gordonii, Actinomyces viscosus, or Lactobacillus acidophilus. J Endod. 2016; 42(8):1233-8. DOI: 10.1016/j.joen.2016.05.002. View

20.

Ma J, Wang Z, Shen Y, Haapasalo M . A new noninvasive model to study the effectiveness of dentin disinfection by using confocal laser scanning microscopy. J Endod. 2011; 37(10):1380-5. DOI: 10.1016/j.joen.2011.06.018. View